Table 3 –
Sarcopenic Obesity (ALM definition) Present/Absent | Sarcopenic Obesity (ALM:BMI definition) Present/Absent | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | |||||||
Outcome Variable | β ± se | p | β ± se | p | β ± se | p | β ± se | p | β ± se | p | β ± se | p |
Non-Fasting | ||||||||||||
Systolic | 1.73±1.06 | 0.11 | 2.13±1.03 | 0.05 | 2.17±1.03 | 0.04 | 2.22±0.88 | 0.02 | 2.12±0.93 | 0.03 | 2.01±0.95 | 0.04 |
Diastolic | 0.092±0.76 | 0.91 | 0.21±0.74 | 0.78 | −0.033±0.72 | 0.96 | −0.46±0.64 | 0.48 | −0.41±0.65 | 0.53 | −0.132±0.66 | 0.84 |
Cholesterol | ||||||||||||
Total | 4.16±2.33 | 0.08 | 4.44±2.33 | 0.06 | 3.55±2.43 | 0.15 | 0.20±2.04 | 0.92 | 0.485±2.03 | 0.81 | 0.87±1.97 | 0.66 |
HDL-C | 5.23±0.78 | <0.001 | 5.86±0.76 | <0.001 | 5.56±0.75 | <0.001 | −1.89±0.53 | 0.001 | −1.06±0.55 | 0.06 | −0.674±0.54 | 0.22 |
Triglycerides | −14.4±3.35 | <0.001 | −16.7±3.33 | <0.001 | −14.7±3.12 | <0.001 | 14.2±3.54 | <0.001 | 10.8±3.57 | 0.004 | 7.80±3.78 | 0.05 |
Ln triglycerides | −0.083±0.02 | <0.001 | −0.101±0.021 | <0.001 | −0.090±0.02 | <0.001 | 0.099±0.02 | <0.001 | 0.074±0.021 | 0.001 | 0.058±0.022 | 0.01 |
Glucose | −3.03±1.59 | 0.06 | −2.59±1.65 | 0.12 | −0.673±1.37 | 0.63 | 6.35±1.52 | <0.001 | 6.34±1.58 | <0.001 | 4.14±1.32 | 0.003 |
Inflammatory | ||||||||||||
C-reactive protein | 0.026±0.04 | 0.51 | 0.044±0.04 | 0.29 | 0.050±0.041 | 0.23 | 0.15±0.04 | <0.001 | 0.164±0.04 | <0.001 | 0.16±0.04 | <0.001 |
Ln crp | −0.061±0.05 | 0.23 | −0.035±0.051 | 0.50 | −0.022±0.05 | 0.67 | 0.406±0.052 | <0.001 | 0.422±0.052 | <0.001 | 0.42±0.05 | <0.001 |
Fibrinogen | 0.83±4.28 | 0.85 | 1.42±4.6 | 0.76 | 2.57±4.65 | 0.59 | 21.3±4.71 | <0.001 | 22.5±4.82 | <0.001 | 21.26±4.77 | <0.001 |
Fasting Variables | ||||||||||||
HOMA-IR | −1.16±0.23 | <0.001 | −1.13±0.21 | <0.001 | −1.03±0.19 | <0.001 | 1.22±0.75 | 0.11 | 1.19±0.76 | 0.13 | 1.14±0.71 | 0.12 |
HOMA-B | −14.3±6.6 | 0.04 | −11.4±8.00 | 0.17 | −12.05±7.69 | 0.13 | −1.51±16.68 | 0.93 | −1.67±16.9 | 0.92 | −1.72±16.4 | 0.92 |
Triglycerides | −8.86±6.28 | 0.17 | −13.8±6.06 | 0.03 | −12.72±5.64 | 0.03 | 16.8±6.85 | 0.02 | 10.6±6.92 | 0.14 | 10.0±6.66 | 0.14 |
Ln triglycerides | −0.043±0.033 | 0.20 | −0.074±0.03 | 0.02 | −0.07±0.03 | 0.02 | 0.104±0.038 | 0.011 | 0.066±0.036 | 0.08 | 0.064±0.035 | 0.08 |
Insulin | −3.27±0.64 | <0.001 | −3.33±0.60 | <0.001 | −3.15±0.54 | <0.001 | 3.04±1.89 | 0.12 | 2.92±1.90 | 0.14 | 2.76±1.78 | 0.13 |
LDL-C | 2.03±0.3.03 | 0.51 | 2.28±3.10 | 0.47 | 1.89±2.92 | 0.52 | −1.07±2.84 | 0.71 | −0.82±2.97 | 0.79 | −1.04±2.71 | 0.71 |
All values represented are from multivariable linear regression models (β coefficient ± standard error) with p-values.
Values bolded are considered statistically significant
Model 1: Adjusted for age, sex
Model 2: Model 1 co-variates, race, education, smoking status, arthritis
Model 3: Model 2 co-variates, diabetes, cancer
Abbreviations: ALM: Appendicular lean mass; BMI: body mass index; HDL-C: high density lipoprotein cholesterol; HOMA: homeostatic assessment model; IR: insulin resistance; LDL-C: low density lipoprotein cholesterol; S-sensitivity; s.e.: standard error.
Natural log transformation was used for triglycerides and C-reactive protein